Another possible explanation is that other factors, besides somatic mutations or decreased mRNA expression (either as a result of copy number variation or epigenetic regulation), act to impair BRCA1 function in sporadic breast cancer. The gene discussed is BRCA1; the disease is breast carcinoma.